A nurse holds a COVID-19 vaccine in Miami, Fla., in this file photograph. Joe Raedle/Getty ImagesPfizer reported a decline in revenue on Nov. 4, which it primarily attributed to lower sales for the company’s COVID-19 vaccine, Comirnaty, and COVID-19 drug, Paxlovid.The company said it made $16.7 billion in revenue in the third quarter, down 7 percent from Q3 2024.
Pfizer COVID-19 Vaccine Sales Drop After CDC Narrows Guidance
Related Articles
Artificial IntelligenceAustralia NewsAustralia Top NewsAustralian Politics NewsBusinessCompaniesDigital PrivacyMedia & Big TechTechWorld News
Google, OpenAI Say US Law Lets Them Train AI on Australian Content Without Seeking Permission
This photograph shows a handheld smartphone displaying the icons of some of...
BusinessCompaniesEconomic PoliciesExecutive BranchUSUS NewsUS Politics
Becton Dickinson to Invest $19 Billion in US Manufacturing
American medical manufacturer Becton Dickinson said Oct. 6 it will invest $19...
BusinessEconomyReal EstateUSUS News
Aging Americans Could Return 14 Million Homes to Market Over Next Decade, Report Says
Aging baby boomers and members of the Silent Generation are expected to...
Arizona NewsAsia & PacificChina NewsEuropeRegional & State NewsSpecial TopicsState NewsTaiwanUSUS NewsUS-China RelationsWorld News
Taiwan Opens Phoenix Office as Arizona Ties Expand
Taiwan Foreign Minister Lin Chia-lung (R) and Arizona Gov. Katie Hobbs unveil...
